Literature DB >> 18771840

Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery.

Danielle Ofir1, Amalia Levy, Arnon Wiznitzer, Moshe Mazor, Eyal Sheiner.   

Abstract

OBJECTIVE: To investigate pregnancy outcome of patients with Familial Mediterranean fever (FMF). STUDY
DESIGN: A population-based study comparing all pregnancies of women with and without FMF between the years 1988 and 2006 was conducted. Stratified analyses, using the Mantel-Haenszel procedure and multiple logistic regression models, were performed to control for confounders.
RESULTS: During the study period there were 175,572 deliveries, of which 239 occurred in patients with FMF. Using a multivariable analysis, the following conditions were significantly associated with FMF: preterm delivery (PTD, <37 weeks) (odds ratio (OR)=1.5; 95% confidence interval (CI) 1.1-2.2), fertility treatments (OR=2.5; 95% CI 1.4-4.4), recurrent abortions (OR=2.2; 95% CI 1.5-3.2), labor induction (OR=1.9; 95% CI 1.5-2.5) and malpresentations (OR=1.8; 95% CI 1.2-2.8). Patients with FMF were more likely to deliver by cesarean delivery (CD) as compared to the comparison group (18.0% vs. 12.8%; P=0.017). However, while controlling for possible confounders such as malpresentations, labor dystocia and failed induction, using multivariable analysis with CD as the outcome variable, FMF was not found as an independent risk factor for CD (adjusted OR=1.2; 95% CI 0.8-1.8, P=0.388). No significant differences were noted between the groups regarding perinatal outcomes such as low Apgar scores (<7) at 1 and 5 min (2.4% vs. 4.3%, P=0.153 and 0.4% vs. 0.6%, P=0.692; respectively), congenital malformations (5.2% vs. 4.9%, P=0.838), or perinatal mortality (0.8% vs. 1.4%, P=0.445). Stratified analysis, using the Mantel-Haenszel technique, was used to assess the association between FMF and PTD while controlling for possible confounders such as iatrogenic labor induction, fertility treatments, recurrent abortions and placental abruption. None of those variables explained the higher incidence of PTD in the group of patients with FMF.
CONCLUSION: Familial Mediterranean fever is an independent risk factor for preterm delivery. Nevertheless, perinatal outcome is comparable to the general population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771840     DOI: 10.1016/j.ejogrb.2008.07.025

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  Pregnancy outcome in patients following different types of bariatric surgeries.

Authors:  Eyal Sheiner; Evgenia Balaban; Jacob Dreiher; Isaac Levi; Amalia Levy
Journal:  Obes Surg       Date:  2009-07-18       Impact factor: 4.129

2.  [IL-1-blockade with Anakinra during pregnancy : Retrospective analysis of efficacy and safety in female patients with familial Mediterranean fever].

Authors:  N Venhoff; R E Voll; C Glaser; J Thiel
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

Review 3.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

4.  The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy.

Authors:  Sharon Daniel; Maya Doron; Boris Fishman; Gideon Koren; Eitan Lunenfeld; Amalia Levy
Journal:  Br J Clin Pharmacol       Date:  2019-12-03       Impact factor: 4.335

Review 5.  The impact of familial Mediterranean fever on reproductive system.

Authors:  Muyesser Nergiz Yanmaz; Ayşet Jane Özcan; Kadir Savan
Journal:  Clin Rheumatol       Date:  2014-06-14       Impact factor: 2.980

Review 6.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

Review 7.  [New aspects of rare rheumatic diseases during pregnancy].

Authors:  Jörg Henes; Ann-Christin Pecher
Journal:  Z Rheumatol       Date:  2021-09-17       Impact factor: 1.372

Review 8.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Xi Yin; Fangyuan Tian; Bin Wu; Ting Xu
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

9.  Thiol/disulphide homeostasis in pregnant women with Familial Mediterranean fever.

Authors:  Aykan Yucel; Cem Yasar Sanhal; Korkut Daglar; Ozgur Kara; Dilek Uygur; Ozcan Erel
Journal:  Redox Rep       Date:  2016-03-31       Impact factor: 4.412

10.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Bin Wu; Ting Xu; Youping Li; Xi Yin
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.